Global and United States Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 13-Sep-2021
No. of pages: 109
Inquire Before Buying

Global Monoclonal Antibody Therapeutics Scope and Market Size

Monoclonal Antibody Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Monoclonal Antibody Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Humanized Antibody

- Human Mouse Chimeric Antibody

Segment by Application

- Cancer

- Autoimmune Diseases

- Infection

- Hematological Diseases

- Ophthalmological Diseases

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Bayer

- F. Hoffmann-La Roche

- Pfizer

- Sanofi

- GlaxoSmithKline

- Merck

- Novartis

- AbbVie

- Amgen

- Johnson & Johnson

- Bristol-Myers Squibb Company

- Biogen

Global and United States Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Humanized Antibody
1.2.3 Human Mouse Chimeric Antibody
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Infection
1.3.5 Hematological Diseases
1.3.6 Ophthalmological Diseases
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Therapeutics Market Perspective (2016-2027)
2.2 Monoclonal Antibody Therapeutics Growth Trends by Regions
2.2.1 Monoclonal Antibody Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Monoclonal Antibody Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Monoclonal Antibody Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Monoclonal Antibody Therapeutics Industry Dynamic
2.3.1 Monoclonal Antibody Therapeutics Market Trends
2.3.2 Monoclonal Antibody Therapeutics Market Drivers
2.3.3 Monoclonal Antibody Therapeutics Market Challenges
2.3.4 Monoclonal Antibody Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue
3.1.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Monoclonal Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Therapeutics Revenue
3.4 Global Monoclonal Antibody Therapeutics Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapeutics Revenue in 2020
3.5 Monoclonal Antibody Therapeutics Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Therapeutics Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Therapeutics Breakdown Data by Type
4.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2022-2027)
5 Monoclonal Antibody Therapeutics Breakdown Data by Application
5.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Monoclonal Antibody Therapeutics Market Size (2016-2027)
6.2 North America Monoclonal Antibody Therapeutics Market Size by Type
6.2.1 North America Monoclonal Antibody Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Monoclonal Antibody Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Monoclonal Antibody Therapeutics Market Size by Type (2016-2027)
6.3 North America Monoclonal Antibody Therapeutics Market Size by Application
6.3.1 North America Monoclonal Antibody Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Monoclonal Antibody Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Monoclonal Antibody Therapeutics Market Size by Application (2016-2027)
6.4 North America Monoclonal Antibody Therapeutics Market Size by Country
6.4.1 North America Monoclonal Antibody Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Monoclonal Antibody Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Monoclonal Antibody Therapeutics Market Size (2016-2027)
7.2 Europe Monoclonal Antibody Therapeutics Market Size by Type
7.2.1 Europe Monoclonal Antibody Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Monoclonal Antibody Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Monoclonal Antibody Therapeutics Market Size by Type (2016-2027)
7.3 Europe Monoclonal Antibody Therapeutics Market Size by Application
7.3.1 Europe Monoclonal Antibody Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Monoclonal Antibody Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Monoclonal Antibody Therapeutics Market Size by Application (2016-2027)
7.4 Europe Monoclonal Antibody Therapeutics Market Size by Country
7.4.1 Europe Monoclonal Antibody Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Monoclonal Antibody Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type
8.2.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application
8.3.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region
8.4.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Therapeutics Market Size (2016-2027)
9.2 Latin America Monoclonal Antibody Therapeutics Market Size by Type
9.2.1 Latin America Monoclonal Antibody Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Monoclonal Antibody Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Monoclonal Antibody Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Monoclonal Antibody Therapeutics Market Size by Application
9.3.1 Latin America Monoclonal Antibody Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Monoclonal Antibody Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Monoclonal Antibody Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Monoclonal Antibody Therapeutics Market Size by Country
9.4.1 Latin America Monoclonal Antibody Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Monoclonal Antibody Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type
10.2.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application
10.3.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country
10.4.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Monoclonal Antibody Therapeutics Introduction
11.1.4 Bayer Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Monoclonal Antibody Therapeutics Introduction
11.3.4 Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Monoclonal Antibody Therapeutics Introduction
11.4.4 Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Monoclonal Antibody Therapeutics Introduction
11.6.4 Merck Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Monoclonal Antibody Therapeutics Introduction
11.7.4 Novartis Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Monoclonal Antibody Therapeutics Introduction
11.8.4 AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.8.5 AbbVie Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Monoclonal Antibody Therapeutics Introduction
11.9.4 Amgen Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.9.5 Amgen Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Introduction
11.10.4 Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
11.11 Bristol-Myers Squibb Company
11.11.1 Bristol-Myers Squibb Company Company Details
11.11.2 Bristol-Myers Squibb Company Business Overview
11.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Introduction
11.11.4 Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.11.5 Bristol-Myers Squibb Company Recent Development
11.12 Biogen
11.12.1 Biogen Company Details
11.12.2 Biogen Business Overview
11.12.3 Biogen Monoclonal Antibody Therapeutics Introduction
11.12.4 Biogen Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.12.5 Biogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Humanized Antibody
Table 3. Key Players of Human Mouse Chimeric Antibody
Table 4. Global Monoclonal Antibody Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Monoclonal Antibody Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Monoclonal Antibody Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Monoclonal Antibody Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Monoclonal Antibody Therapeutics Market Share by Regions (2022-2027)
Table 10. Monoclonal Antibody Therapeutics Market Trends
Table 11. Monoclonal Antibody Therapeutics Market Drivers
Table 12. Monoclonal Antibody Therapeutics Market Challenges
Table 13. Monoclonal Antibody Therapeutics Market Restraints
Table 14. Global Monoclonal Antibody Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Monoclonal Antibody Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapeutics as of 2020)
Table 17. Ranking of Global Top Monoclonal Antibody Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Monoclonal Antibody Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Monoclonal Antibody Therapeutics Product Solution and Service
Table 21. Date of Enter into Monoclonal Antibody Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Monoclonal Antibody Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Monoclonal Antibody Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Monoclonal Antibody Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Monoclonal Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Monoclonal Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Monoclonal Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Monoclonal Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Monoclonal Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Monoclonal Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Monoclonal Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Monoclonal Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Monoclonal Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Monoclonal Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Monoclonal Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Monoclonal Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Monoclonal Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Monoclonal Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Monoclonal Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bayer Company Details
Table 62. Bayer Business Overview
Table 63. Bayer Monoclonal Antibody Therapeutics Product
Table 64. Bayer Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Bayer Recent Development
Table 66. F. Hoffmann-La Roche Company Details
Table 67. F. Hoffmann-La Roche Business Overview
Table 68. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product
Table 69. F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 70. F. Hoffmann-La Roche Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Monoclonal Antibody Therapeutics Product
Table 74. Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Sanofi Company Details
Table 77. Sanofi Business Overview
Table 78. Sanofi Monoclonal Antibody Therapeutics Product
Table 79. Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Sanofi Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Monoclonal Antibody Therapeutics Product
Table 84. GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Monoclonal Antibody Therapeutics Product
Table 89. Merck Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Merck Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Monoclonal Antibody Therapeutics Product
Table 94. Novartis Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Novartis Recent Development
Table 96. AbbVie Company Details
Table 97. AbbVie Business Overview
Table 98. AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 99. AbbVie Recent Development
Table 100. Amgen Company Details
Table 101. Amgen Business Overview
Table 102. Amgen Monoclonal Antibody Therapeutics Product
Table 103. Amgen Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Amgen Recent Development
Table 105. Johnson & Johnson Company Details
Table 106. Johnson & Johnson Business Overview
Table 107. Johnson & Johnson Monoclonal Antibody Therapeutics Product
Table 108. Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Johnson & Johnson Recent Development
Table 110. Bristol-Myers Squibb Company Company Details
Table 111. Bristol-Myers Squibb Company Business Overview
Table 112. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product
Table 113. Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Bristol-Myers Squibb Company Recent Development
Table 115. Biogen Company Details
Table 116. Biogen Business Overview
Table 117. Biogen Monoclonal Antibody Therapeutics Product
Table 118. Biogen Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Biogen Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Humanized Antibody Features
Figure 3. Human Mouse Chimeric Antibody Features
Figure 4. Global Monoclonal Antibody Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Cancer Case Studies
Figure 6. Autoimmune Diseases Case Studies
Figure 7. Infection Case Studies
Figure 8. Hematological Diseases Case Studies
Figure 9. Ophthalmological Diseases Case Studies
Figure 10. Others Case Studies
Figure 11. Monoclonal Antibody Therapeutics Report Years Considered
Figure 12. Global Monoclonal Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Monoclonal Antibody Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Monoclonal Antibody Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Monoclonal Antibody Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Monoclonal Antibody Therapeutics Market Share by Players in 2020
Figure 17. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Monoclonal Antibody Therapeutics Revenue in 2020
Figure 19. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Monoclonal Antibody Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Monoclonal Antibody Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Monoclonal Antibody Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Monoclonal Antibody Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Monoclonal Antibody Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Monoclonal Antibody Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Monoclonal Antibody Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Monoclonal Antibody Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Monoclonal Antibody Therapeutics Market Share by Region (2016-2027)
Figure 41. China Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Monoclonal Antibody Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Monoclonal Antibody Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Monoclonal Antibody Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Monoclonal Antibody Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Monoclonal Antibody Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Monoclonal Antibody Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Bayer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 61. F. Hoffmann-La Roche Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 67. AbbVie Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 68. Amgen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 69. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 70. Bristol-Myers Squibb Company Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 71. Biogen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
  • Global and United States Surgical Catheters Market Insights, Forecast to 2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 161
    Surgical Catheters market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Surgical Catheters market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Surgical Ca......
  • Global and Japan Surgical Smoke Aspirators Market Insights, Forecast to 2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 144
    Surgical Smoke Aspirators market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Surgical Smoke Aspirators market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Surgi......
  • Global and China Orthopedic Instruments Market Insights, Forecast to 2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 166
    Orthopedic Instruments market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Orthopedic Instruments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Orthopedic ......
  • Global and United States Nasal Cannulas Market Insights, Forecast to 2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 134
    Nasal Cannulas market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nasal Cannulas market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Nasal Cannulas mark......
  • Global and China Molecular Diagnostics Systems Market Insights, Forecast to 2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 149
    Molecular Diagnostics Systems market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on t......
  • Global and China LED Phototherapy System Market Insights, Forecast to 2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 146
    LED Phototherapy System market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global LED Phototherapy System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the LED Photo......
  • Global and United States Bone Marrow Aspiration and Biopsy Market Size, Status and Forecast 2021-2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 105
    Global Bone Marrow Aspiration and Biopsy Scope and Market Size Bone Marrow Aspiration and Biopsy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bone Marrow Aspiration and Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 201......
  • Global and China HDL Cholesterol Market Size, Status and Forecast 2021-2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 109
    Global HDL Cholesterol Scope and Market Size HDL Cholesterol market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global HDL Cholesterol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type - Regent......
  • Global and United States Hepatitis B Testing Market Size, Status and Forecast 2021-2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 106
    Global Hepatitis B Testing Scope and Market Size Hepatitis B Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis B Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs